The move means that vaccines for this age group will not be available in the coming weeks.
in its trial of children ages 2 to 4. For young children, Pfizer’s vaccine has a dosage of 3 micrograms. For children ages 5 to 11, the dosage is higher, at 10 micrograms.
The FDA was expected to publish an analysis of the Pfizer data Friday, ahead of an advisory committee meeting next week. “I think that they will be pleased with the data and they will approve,” Bourla told CNBC’s Meg Tirrell, while noting that the regulatory process still has to play out.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA postpones advisory panel meeting on Pfizer Covid-19 vaccine for younger childrenThe US Food and Drug Administration is postponing an advisory panel meeting on authorizing Pfizer’s Covid-19 vaccine in children under 5.
Lire la suite »
Pfizer postpones FDA request for Covid vaccine for kids under 5The company said it believes three doses 'may provide a higher level of protection in this age group.'
Lire la suite »
Pfizer Postpones Request To Give COVID Vaccines To Kids Under 5The company said it will wait until it has more data on a third dose.
Lire la suite »
FDA delays meeting on kid vaccines as Pfizer promises more dataThe companies have been testing a third shot after announcing in December that trial data showed two doses produced an insufficient immune response in toddlers.
Lire la suite »
Pfizer postpones FDA request for Covid vaccine for kids under 5The company said it believes three doses 'may provide a higher level of protection in this age group.'
Lire la suite »